Author

Hae‐Ji Kang

Georgia State UniversityORCID 0000-0001-6405-9042Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alexander A. KolykhaloviD· 1 shared Alexander L. GreningeriD· 1 shared Andrew T. GewirtziD· 1 shared Carolin M. LieberiD· 1 shared Elizabeth B. SobolikiD· 1 shared Mehul S. SuthariD· 1 shared Michael G. NatchusiD· 1 shared Richard Karl PlemperiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alexander A. KolykhalovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologyJournal of VirologyPeer-reviewedAug 29, 2024

Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infection

Carolin M. Lieber, Hae‐Ji Kang, Elizabeth B. Sobolik…·Richard Karl Plemper

This study evaluates late-onset antiviral treatment in immunocompromised mice with persistent SARS-CoV-2 infection, finding that 4-FlU significantly reduces virus load, while paxlovid causes viral rebound.

13 citations

mouseexperimental assay

𝕏 PostBluesky